CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 160 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,567,093 | +45.0% | 93,281 | +78.8% | 0.00% | 0.0% |
Q2 2023 | $1,770,467 | +17.4% | 52,180 | +24.5% | 0.00% | 0.0% |
Q1 2023 | $1,507,562 | -19.3% | 41,900 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,867,483 | +58.5% | 41,900 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $1,178,000 | +4.2% | 41,900 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,130,000 | -19.1% | 41,900 | +2.2% | 0.00% | 0.0% |
Q1 2022 | $1,396,000 | -11.6% | 41,000 | +0.2% | 0.00% | 0.0% |
Q4 2021 | $1,580,000 | -28.4% | 40,900 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $2,208,000 | +61.4% | 40,900 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,368,000 | – | 40,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |